Recombinant Bacillus subtilis Multidrug resistance protein ykkD (ykkD)

Shipped with Ice Packs
In Stock

Description

Introduction to Recombinant Bacillus subtilis Multidrug Resistance Protein ykkD

The recombinant Bacillus subtilis multidrug resistance protein ykkD is a protein encoded by the gene ykkD in the bacterium Bacillus subtilis. This protein is part of a multidrug efflux system that helps bacteria resist various drugs and toxic compounds. The ykkD protein is often studied in conjunction with its partner protein ykkC, as they form a heterodimeric complex that functions as a Small Multidrug Resistance (SMR) efflux pump .

Structure and Function

  • Structure: The ykkD protein is a 105-amino acid protein, and its structure is typically studied in the context of its interaction with ykkC to form a functional efflux pump .

  • Function: The primary function of the ykkD-ykkC complex is to efflux a variety of drugs and toxic compounds from the bacterial cell, thereby contributing to multidrug resistance. This complex is particularly noted for its role in alleviating guanidine toxicity, as its expression is regulated by a riboswitch that senses guanidine levels .

Expression and Production

  • Expression Region: The full-length ykkD protein is expressed from the BSU13100 locus in Bacillus subtilis .

  • Production: Recombinant ykkD protein is available commercially, often produced in a recombinant form for research purposes. It is typically stored in a Tris-based buffer with 50% glycerol at -20°C to maintain stability .

Role in Guanidine Metabolism

The ykkD-ykkC complex plays a crucial role in the metabolism of guanidine, a compound that can be toxic to bacteria at high concentrations. The expression of these proteins is controlled by a riboswitch that senses guanidine levels, ensuring that the efflux pump is active when needed to reduce intracellular guanidine concentrations .

Interaction with Other Proteins

The ykkD protein interacts with ykkC to form a functional efflux pump. This interaction is essential for the proper functioning of the pump in drug resistance. Other proteins involved in similar efflux systems include EbrA and EbrB in Bacillus subtilis .

Protein Details

Protein DetailDescription
Protein NameMultidrug resistance protein ykkD
Gene NameykkD
Ordered Locus NameBSU13100
SpeciesBacillus subtilis (strain 168)
Uniprot NumberP49857
Sequence Length105 amino acids

References PubMed: Casein kinase I-like protein kinases encoded by YCK1 and YCK2. Yale Protein Expression Database (YPED) - Yale School of Medicine. GeneBioSystems: Recombinant Bacillus subtilis Multidrug resistance protein ykkD. PMC: Metabolism of Free Guanidine in Bacteria is Regulated by a Riboswitch. Nature: Design and applications of a clamp for Green Fluorescent Protein. SubtiWiki: ykkD. PMC: A Broad-Specificity Multidrug Efflux Pump Requiring a Pair of Proteins.

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference in order notes for customized fulfillment.
Lead Time
Delivery times vary depending on the purchasing method and location. Please contact your local distributor for precise delivery estimates.
Note: Standard shipping includes blue ice packs. Dry ice shipping requires prior arrangement and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to collect the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50% and serves as a guideline.
Shelf Life
Shelf life depends on various factors including storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized forms have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquot to prevent repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing.
The specific tag type is determined during production. If you require a specific tag, please inform us for preferential development.
Synonyms
gdnD; ykkD; BSU13100; Probable guanidinium efflux system subunit GdnD
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-105
Protein Length
full length protein
Species
Bacillus subtilis (strain 168)
Target Names
ykkD
Target Protein Sequence
MLHWISLLCAGCLEMAGVALMNQYAKEKSVKWVLLIIVGFAASFSLLSYAMETTPMGTAY AVWTGIGTAGGALIGILFYKEQKDAKRIFFIALILCSAVGLKILS
Uniprot No.

Target Background

Function

Function: Likely involved in guanidinium transport. In vitro studies demonstrate resistance to a broad spectrum of toxic compounds, including cationic dyes and neutral and anionic antimicrobials.

Database Links
Protein Families
Small multidrug resistance (SMR) protein family, YkkC/YkkD (TC 2.A.7.1.5) subfamily
Subcellular Location
Cell membrane; Multi-pass membrane protein.

Q&A

What is the ykkD protein and what is its role in Bacillus subtilis?

The ykkD protein is an SMR-type (Small Multidrug Resistance) protein that functions as a subunit of the ykkCD efflux pump in Bacillus subtilis. It plays a crucial role in antibiotic resistance through its participation in active efflux of multiple antimicrobial compounds. As part of the ykkCD system, it helps expel various antibiotics from bacterial cells, including phenicols, tetracyclines, and aminoglycosides, thereby reducing their intracellular concentration to sub-lethal levels . The ykkD protein represents one component of the broader antimicrobial defense mechanisms in B. subtilis that contribute to its intrinsic resistance capabilities.

Which antibiotic classes are affected by ykkD-mediated resistance?

The ykkD protein, as part of the ykkCD efflux system, contributes to resistance against multiple classes of antibiotics. Based on current research, these include:

Antibiotic ClassExamplesResistance Mechanism
Phenicol antibioticsChloramphenicolAntibiotic efflux
Tetracycline antibioticsTetracyclineAntibiotic efflux
Aminoglycoside antibioticsStreptomycinAntibiotic efflux

The efflux activity mediated by ykkD results in decreased intracellular accumulation of these antibiotics, thereby conferring resistance . This multi-substrate specificity is a hallmark of SMR-type efflux pumps and represents an important mechanism of intrinsic antimicrobial resistance in B. subtilis.

How does the ykkCD efflux system compare to other multidrug resistance systems in B. subtilis?

B. subtilis possesses several multidrug resistance systems, with the ykkCD and EbrAB systems being notable examples. While both confer resistance through efflux mechanisms, they exhibit distinct characteristics:

FeatureykkCD SystemEbrAB System
Protein FamilySmall Multidrug Resistance (SMR)Small Multidrug Resistance (SMR)
Resistance ProfilePhenicols, tetracyclines, aminoglycosides Ethidium bromide, acriflavine, pyronine Y, safranin O
Component StructureTwo-component system (ykkC and ykkD)Two-component system (EbrA and EbrB)
Energy DependenceEnergy-dependent effluxEnergy-dependent efflux

The EbrAB system has been experimentally demonstrated to confer a several-fold increase in minimum inhibitory concentrations (MICs) for specific compounds like ethidium bromide when expressed in both E. coli and B. subtilis hosts . Understanding these different resistance systems provides insights into the comprehensive antimicrobial defense mechanisms of B. subtilis.

What are the recommended methods for cloning and expressing recombinant ykkD protein?

For successful cloning and expression of recombinant ykkD protein, researchers should consider the following methodological approach:

  • Gene Amplification: Design primers specific to the ykkD gene sequence from B. subtilis genomic DNA, including appropriate restriction sites for subsequent cloning. PCR conditions should be optimized based on the GC content of the target sequence.

  • Vector Selection: Choose an expression vector compatible with both E. coli (for cloning) and B. subtilis (for functional studies). Vectors like pMutin series have been successfully used for similar proteins in B. subtilis .

  • Transformation Strategy:

    • For E. coli: Standard heat-shock transformation with selection on appropriate antibiotics

    • For B. subtilis: Natural competence-based transformation with selection for resistance markers (e.g., erythromycin at 0.5 μg/ml)

  • Expression Verification: Confirm successful expression through:

    • Western blotting with anti-His tag antibodies (if a tag is included)

    • RT-PCR to detect mRNA expression

    • Functional assays measuring antibiotic resistance profiles

The methodology should include verification of recombination through Southern blotting and PCR, similar to approaches used for other B. subtilis proteins . Expression systems utilizing inducible promoters allow for controlled production of the recombinant protein.

How can researchers effectively measure the activity of recombinant ykkD protein?

Measuring the activity of recombinant ykkD protein requires multiple complementary approaches:

Antibiotic Susceptibility Testing:

  • Determine Minimum Inhibitory Concentrations (MICs) for relevant antibiotics (chloramphenicol, tetracycline, streptomycin) in strains expressing recombinant ykkD versus control strains.

  • Conduct disk diffusion assays to visualize and quantify zones of inhibition.

Direct Efflux Measurements:

  • Fluorescent substrate accumulation assays using known substrates (e.g., ethidium bromide)

  • Real-time monitoring of substrate efflux using fluorescence spectroscopy

Functional Reconstitution:

  • Purify recombinant ykkD protein and reconstitute in liposomes

  • Measure transport activity using fluorescent or radioactively labeled substrates

When expressing ykkD in heterologous systems, researchers should account for potential differences in membrane composition and partner proteins that might affect functional activity. Comparison with knockout strains lacking ykkD can provide valuable controls to establish the specific contribution of ykkD to observed resistance phenotypes .

What approaches can be used to study ykkD's interaction with its partner protein ykkC?

Studying the interaction between ykkD and ykkC requires techniques that can detect and characterize protein-protein interactions in membrane systems:

  • Co-immunoprecipitation (Co-IP): Using antibodies against either ykkC or ykkD to pull down the protein complex, followed by Western blot detection of the partner protein.

  • Bacterial Two-Hybrid System: Adapting yeast two-hybrid methodology for bacterial membrane proteins to detect interactions in vivo.

  • Förster Resonance Energy Transfer (FRET): Tagging ykkC and ykkD with appropriate fluorophores to detect proximity-based energy transfer, indicating interaction.

  • Cross-linking Studies: Chemical cross-linking of the protein complex followed by mass spectrometry analysis to identify interaction domains.

  • Genetic Complementation: Testing whether expression of both components is necessary for functional resistance, similar to studies with EbrAB where neither component alone conferred resistance .

Studies with other SMR family proteins have demonstrated that both components of two-component systems are typically required for full functionality. For instance, with the EbrAB system in B. subtilis, neither EbrA nor EbrB alone conferred drug resistance, suggesting obligate cooperation between the partner proteins . Similar methodologies can be applied to investigate the interdependence of ykkC and ykkD proteins.

How does the structure of ykkD contribute to its substrate specificity?

The structure-function relationship of ykkD represents an area requiring sophisticated structural biology approaches. Current understanding suggests:

  • Transmembrane Domain Architecture: ykkD likely possesses multiple transmembrane helices that form substrate binding pockets and transport channels. Homology modeling based on other SMR family proteins can provide initial structural insights.

  • Critical Residues for Substrate Recognition: Site-directed mutagenesis targeting conserved residues within predicted substrate-binding pockets can identify amino acids critical for substrate specificity. Researchers should prioritize:

    • Aromatic residues often involved in stacking interactions with substrates

    • Charged residues that may interact with ionic substrates

    • Conserved motifs identified through sequence alignment with other SMR proteins

  • Structural Dynamics During Transport: Advanced techniques such as hydrogen-deuterium exchange mass spectrometry (HDX-MS) can provide insights into conformational changes associated with substrate binding and transport.

What are the regulatory mechanisms controlling ykkCD expression in B. subtilis?

Understanding the regulation of ykkCD expression requires investigation at multiple levels:

  • Transcriptional Regulation:

    • Analysis of the promoter region for binding sites of known transcriptional regulators

    • Chromatin immunoprecipitation (ChIP) to identify transcription factors binding to the ykkCD promoter

    • Reporter gene assays using the ykkCD promoter fused to reporter genes like GFP or lacZ

  • Environmental Triggers:

    • Examination of expression patterns under diverse stress conditions:

      • Antibiotic exposure

      • Oxidative stress

      • Nutrient limitation

      • pH variations

  • Post-transcriptional Regulation:

    • Analysis of mRNA stability and potential riboswitches

    • Investigation of small RNA regulation

Unlike some other B. subtilis genes like yabG, which is regulated by SigK RNA polymerase and expressed during sporulation , the regulatory mechanisms of ykkCD likely respond to different environmental cues related to antimicrobial stress. Researchers studying ykkCD regulation should examine both constitutive expression patterns and inducible responses to various antibiotics to determine if the system is constitutively expressed or stress-induced.

What are the challenges in developing inhibitors targeting the ykkD efflux system?

Developing effective inhibitors for the ykkD efflux system presents several research challenges:

  • Target Accessibility: As a membrane protein, ykkD presents difficulties for inhibitor binding due to its hydrophobic environment and potential location within the lipid bilayer.

  • Selectivity Concerns: Designing inhibitors that specifically target ykkD without affecting human transporters requires detailed understanding of structural differences. Researchers must:

    • Identify unique structural features of ykkD not present in human homologs

    • Screen for compounds that selectively bind these unique features

    • Validate selectivity through testing against human cell lines

  • Resistance Development: Even successful inhibitors may face rapid development of resistance through:

    • Mutations in the ykkD binding site

    • Upregulation of alternative efflux systems

    • Modification of cell envelope permeability

  • Validation Challenges:

    • Confirming target engagement in intact bacterial cells

    • Distinguishing between direct inhibition and indirect effects

    • Establishing correlation between in vitro and in vivo efficacy

A promising research direction involves combination approaches where efflux inhibitors are paired with conventional antibiotics to restore susceptibility. This strategy requires careful pharmacokinetic and pharmacodynamic studies to ensure compatible properties between the inhibitor and antibiotic partners .

How does ykkD compare functionally with SMR family proteins in other bacterial species?

The SMR family proteins are widely distributed across bacterial species, with ykkD in B. subtilis representing one member of this extensive family. Comparative analysis reveals:

OrganismSMR ProteinSubstrate SpecificityStructural FeaturesRegulatory Context
B. subtilisykkDPhenicols, tetracyclines, aminoglycosides Two-component system with ykkCUnder investigation
B. subtilisEbrABEthidium bromide, acriflavine, pyronine Y, safranin O Two-component systemFunctional in both B. subtilis and E. coli
E. coliEmrEQuaternary ammonium compounds, ethidiumSingle-component SMRWell-characterized prototype SMR

The two-component nature of ykkCD shares similarities with EbrAB, where both components are required for full functionality . This contrasts with single-component SMR proteins like EmrE in E. coli. Functional studies have shown that while some SMR proteins can operate in heterologous hosts (as demonstrated with EbrAB functioning in E. coli ), the efficiency may vary depending on membrane composition and cellular environment.

Researchers investigating ykkD should consider these comparative aspects when designing experiments and interpreting results, particularly when using heterologous expression systems or making functional predictions based on homology.

How can we differentiate the specific contributions of ykkD from other resistance mechanisms in B. subtilis?

Differentiating the specific contributions of ykkD from other resistance mechanisms requires sophisticated genetic and biochemical approaches:

  • Genetic Approaches:

    • Construction of clean deletion mutants (ΔykkD) using Cre/lox systems similar to those used for other B. subtilis genes

    • Creation of multiple knockout strains lacking combinations of efflux pumps

    • Complementation studies with controlled expression of ykkD

  • Biochemical Approaches:

    • Substrate profiling using purified ykkD protein

    • Competition assays with known substrates to establish specificity profiles

    • Direct transport measurements with reconstituted systems

  • Transcriptomic Analysis:

    • RNA-seq to identify compensatory responses when ykkD is deleted

    • Identification of co-regulated genes that may contribute to resistance

The construction of chassis strains with controlled genetic backgrounds, similar to those developed for other B. subtilis studies , provides a powerful tool for isolating the specific contributions of ykkD. When creating such strains, researchers should be cautious about potential growth defects or physiological changes that might indirectly affect antibiotic susceptibility, as observed with some autolysis gene knockouts in B. subtilis .

What insights can studies of ykkD provide for understanding broader antibiotic resistance mechanisms?

Studies of ykkD can provide valuable insights into broader antibiotic resistance mechanisms:

  • Multidrug Resistance Evolution: Analysis of ykkD's substrate binding mechanisms may reveal how a single protein can recognize structurally diverse compounds, informing our understanding of multidrug resistance evolution.

  • Resistance Network Interactions: Mapping interactions between ykkD and other resistance mechanisms can reveal:

    • Compensatory responses when one system is inhibited

    • Synergistic effects between different resistance mechanisms

    • Hierarchical organization of defense systems

  • Host-Specific Adaptations: Comparing ykkD function across different Bacillus species (B. subtilis, B. halotolerans, B. tequilensis) where sequence variants exist can reveal host-specific adaptations to different ecological niches and antimicrobial pressures.

  • Translational Applications: Insights from ykkD studies may inform:

    • Novel inhibitor design strategies applicable to other SMR family proteins

    • Predictive models for resistance development

    • Biomarker identification for monitoring resistance emergence

By integrating findings from ykkD research with broader studies of antimicrobial resistance mechanisms, researchers can contribute to a more comprehensive understanding of how bacteria defend against antibiotics and potentially identify novel vulnerability points for therapeutic intervention.

How can ykkD be integrated into engineered B. subtilis chassis strains for biotechnology applications?

The integration of ykkD into engineered B. subtilis chassis strains offers potential advantages for biotechnology applications:

  • Improved Tolerance to Toxic Compounds: Enhanced expression of ykkD could increase tolerance to toxic metabolites or substrates in industrial fermentation processes. This approach aligns with recent efforts in designing robust B. subtilis chassis cells that can tolerate toxic substrates like hydroquinone .

  • Integration Methodologies:

    • Chromosome integration using homologous recombination

    • Expression under constitutive or inducible promoters depending on application

    • Co-expression with partner protein ykkC to ensure functional complex formation

  • Optimized Expression Strategies:

    • Codon optimization for improved expression

    • Fusion with fluorescent markers (like GFP) for monitoring expression and localization, similar to approaches used with YabG-GFP fusions

    • Fine-tuning expression levels to balance beneficial effects with potential metabolic burden

  • Performance Evaluation Metrics:

    • Growth rate in the presence of toxic compounds

    • Productivity of target metabolites

    • Long-term strain stability

When designing such chassis strains, researchers should consider the lifespan engineering approach demonstrated for other B. subtilis modifications, where systematic cell lifespan alterations led to improved industrial production characteristics . The experience with strains like CRE15TG, which showed a 1.98-fold increase in L-glutaminase activity, and CRE15A, which demonstrated a 1.34-fold increase in α-arbutin yield , provides a valuable framework for chassis optimization strategies.

What experimental approaches can determine if ykkD expression affects heterologous protein production in B. subtilis?

To determine the impact of ykkD expression on heterologous protein production in B. subtilis, researchers should implement a systematic experimental approach:

  • Controlled Expression System Setup:

    • Construction of isogenic strains differing only in ykkD expression levels

    • Development of inducible systems allowing titration of ykkD expression

    • Integration of reporter proteins (e.g., luciferase, fluorescent proteins) as model heterologous proteins

  • Multi-parameter Analysis:

    • Protein yield quantification using standard methods (Western blot, activity assays)

    • Analysis of protein quality (correct folding, activity)

    • Secretion efficiency for exported proteins

    • Growth characteristics and metabolic burden assessment

  • Stress Response Evaluation:

    • Transcriptomic analysis to identify potential stress responses

    • Monitoring of unfolded protein response activation

    • Assessment of cell envelope integrity

  • Process-relevant Conditions Testing:

    • Performance under various growth conditions (different media, temperature, pH)

    • Behavior in scaled-up cultivation systems (bioreactors vs. shake flasks)

    • Long-term stability of expression over multiple generations

This experimental design should incorporate appropriate controls similar to those used in other B. subtilis engineering studies, such as comparing against parental wild-type strains under identical conditions . Researchers should be particularly attentive to potential indirect effects of ykkD expression on cell physiology that might influence protein production beyond direct interactions with the heterologous proteins.

How might ykkD function be exploited for improving B. subtilis survival in challenging environmental conditions?

Exploiting ykkD function for improving B. subtilis survival in challenging environments represents an advanced application with significant potential:

  • Stress Resistance Enhancement:

    • Engineered overexpression of ykkD may provide increased resistance to environmental toxins sharing structural similarities with antibiotic substrates

    • Integration with other stress response modifications to create multi-resistant strains

  • Biofilm and Persistent Forms:

    • Investigation of ykkD's role in biofilm formation and maintenance

    • Potential contribution to formation of persistent forms under stress conditions

    • Engineered expression in specific subpopulations to enhance community survival

  • Integration with Lifespan Engineering:

    • Combining ykkD modification with chronological lifespan engineering approaches

    • Coordination with autolysis resistance modifications (deletion of lytC, sigD, pcfA, flgD) that have been shown to increase B. subtilis biomass by 20-38%

    • Assessment of synergistic effects with prophage and spore-associated gene modifications

  • Environmental Remediation Applications:

    • Development of B. subtilis strains with enhanced tolerance to environmental pollutants for bioremediation applications

    • Engineering strains capable of surviving and functioning in contaminated environments

The approach to exploiting ykkD should be guided by a systems biology perspective, recognizing that excessive modification of functional genes may cause unpredictable or cascading impairments in cell function, as observed in some multiple-knockout B. subtilis strains . Careful phenotypic characterization is essential, including assessment of viable cell numbers rather than relying solely on optical density measurements to confirm true enhancement of survival capacity.

What are the most promising approaches for structural characterization of the ykkCD complex?

Structural characterization of the ykkCD complex presents significant challenges due to its membrane-embedded nature, but several promising approaches warrant investigation:

  • Cryo-Electron Microscopy (Cryo-EM):

    • Single-particle analysis of purified ykkCD complex

    • Use of innovative membrane mimetics like nanodiscs or amphipols to maintain native-like environment

    • Implementation of recent advances in sample preparation for small membrane proteins

  • X-ray Crystallography with Advanced Techniques:

    • Lipidic cubic phase crystallization

    • Fusion protein approaches to enhance crystallization properties

    • Antibody fragment co-crystallization to stabilize specific conformations

  • Integrative Structural Biology:

    • Combining lower-resolution techniques (small-angle X-ray scattering, electron paramagnetic resonance) with computational modeling

    • Cross-linking mass spectrometry to identify interaction interfaces

    • Hydrogen-deuterium exchange mass spectrometry to map solvent-accessible regions

  • In Silico Approaches:

    • AlphaFold2 or RoseTTAFold prediction with custom modifications for membrane proteins

    • Molecular dynamics simulations in explicit membrane environments

    • Evolutionary coupling analysis to identify co-evolving residues at protein-protein interfaces

The recent successful structural determination of other challenging membrane transporters suggests that a combination of these approaches will be most effective. Researchers should prioritize capturing different conformational states of the complex to understand the transport mechanism fully .

What novel strategies could overcome antimicrobial resistance mediated by ykkD and related efflux pumps?

Developing strategies to overcome ykkD-mediated resistance requires innovative approaches beyond traditional inhibitor design:

  • Collateral Sensitivity Exploitation:

    • Identification of compounds that are preferentially toxic to strains overexpressing ykkD

    • Mapping of evolutionary trade-offs where increased resistance to one compound increases sensitivity to another

    • Design of alternating treatment regimens exploiting these trade-offs

  • Anti-evolution Strategies:

    • Development of compound combinations that suppress resistance evolution

    • Creation of molecules that simultaneously inhibit multiple resistance mechanisms

    • Design of drugs that maintain activity despite target modification

  • Novel Delivery Approaches:

    • Trojan horse strategies using ykkD substrates as delivery vehicles

    • Nanoparticle formulations designed to bypass efflux

    • Local concentration enhancement technologies to overwhelm pump capacity

  • Bacterial Population Control:

    • Targeting bacterial communication systems that regulate ykkD expression

    • Exploitation of persister cell formation dynamics

    • Biofilm disruption strategies combined with efflux inhibition

These approaches should be evaluated not only for immediate efficacy but also for their impact on resistance evolution. Long-term evolution experiments, similar to those used to develop robust B. subtilis chassis strains , could provide valuable insights into the durability of these strategies against adaptive resistance mechanisms.

What are the most effective purification methods for obtaining active recombinant ykkD protein?

Purifying active membrane proteins like ykkD requires specialized approaches to maintain structural integrity and function:

  • Optimal Expression System Selection:

    • Evaluation of expression hosts (E. coli, B. subtilis, yeast systems)

    • Testing of different membrane-protein optimized strains (e.g., C41/C43 for E. coli)

    • Comparison of fusion partners (MBP, SUMO, GFP) for enhanced expression and solubility

  • Detergent Screening Protocol:

    • Systematic testing of detergent types (mild non-ionic, zwitterionic, sterol-based)

    • Detergent concentration optimization for extraction efficiency vs. activity retention

    • Implementation of high-throughput thermal stability assays to identify optimal detergent conditions

  • Advanced Purification Strategy:

    • Two-step affinity chromatography (e.g., Ni-NTA followed by StrepTactin)

    • Size exclusion chromatography to isolate monodisperse protein

    • Lipid addition during purification to maintain native-like environment

  • Functional Validation:

    • Development of in vitro transport assays using proteoliposomes

    • Substrate binding assays using techniques like microscale thermophoresis

    • Structural integrity assessment via circular dichroism spectroscopy

The purification protocol should be designed to co-purify ykkD with its partner protein ykkC when studying the complete functional complex. Researchers should optimize tag placement (N- versus C-terminal) based on topology predictions to minimize interference with function, drawing on experience with other membrane protein purification protocols .

How can researchers effectively measure the kinetics of antibiotic efflux mediated by ykkD?

Measuring antibiotic efflux kinetics requires sophisticated biophysical techniques:

  • Real-time Fluorescence-based Assays:

    • Utilization of fluorescent substrates (e.g., ethidium bromide, SYTO dyes)

    • Development of stopped-flow kinetic measurements

    • Implementation of FRET-based approaches for conformational changes during transport

  • Radioactive Substrate Transport:

    • Use of radiolabeled antibiotics for direct transport measurements

    • Time-course sampling to establish initial rates

    • Competition assays to determine substrate preferences

  • Electrophysiological Approaches:

    • Reconstitution into planar lipid bilayers for electrical measurements

    • Solid-supported membrane electrophysiology for high-throughput screening

    • Patch-clamp methods for single-transporter analysis

  • Mathematical Modeling:

    • Development of kinetic models incorporating:

      • Substrate binding

      • Conformational changes

      • Release steps

    • Fitting of experimental data to discriminate between transport mechanisms

    • System-level modeling of efflux impact on cellular antibiotic concentrations

When designing these experiments, researchers should carefully control for factors that can influence transport rates, including membrane potential, pH gradients, and lipid composition. The kinetic parameters derived from these studies (Km, Vmax, substrate specificity constants) provide valuable quantitative measures for comparing ykkD with other efflux systems and for evaluating the impact of mutations or inhibitors .

What are the best approaches for studying ykkD expression and localization in living B. subtilis cells?

Studying expression and localization of ykkD in living cells requires sophisticated microscopy and molecular biology techniques:

  • Fluorescent Protein Fusions:

    • Construction of chromosomally integrated ykkD-GFP (or other fluorescent protein) fusions

    • Validation of fusion protein functionality through resistance phenotype testing

    • Optimization of linker regions to minimize interference with protein folding and function

  • Super-resolution Microscopy:

    • Implementation of techniques like PALM, STORM or STED for sub-diffraction resolution

    • Dual-color imaging to investigate co-localization with other membrane proteins

    • Time-lapse imaging to track dynamic changes in localization

  • Quantitative Expression Analysis:

    • Development of specific antibodies for immunofluorescence and Western blotting

    • Implementation of ribosome profiling to measure translation efficiency

    • Single-cell analysis using fluorescence-activated cell sorting (FACS)

  • Inducible Expression Systems:

    • Creation of strains with tightly controlled inducible promoters

    • Dose-response studies correlating expression levels with resistance phenotypes

    • Pulse-chase experiments to determine protein turnover rates

These approaches should draw on experience with other B. subtilis membrane proteins, where successful integration of fluorescent protein genes has been achieved using plasmids like pMm2 and appropriate integration strategies . When designing experiments, researchers should consider the potential impact of cell wall structure and membrane microdomains on protein localization and function.

How can researchers address potential artifacts in ykkD functional studies?

Addressing potential artifacts in ykkD functional studies requires rigorous experimental design and appropriate controls:

  • Expression Level Artifacts:

    • Implementation of tightly controlled expression systems

    • Quantification of protein levels in all experimental conditions

    • Titration experiments to establish dose-response relationships

  • Membrane Integrity Concerns:

    • Monitoring of membrane potential using fluorescent dyes

    • Assessment of membrane permeability with impermeant compounds

    • Measurement of growth rates to detect general physiological effects

  • Indirect Effects vs. Direct Function:

    • Comprehensive phenotyping beyond antibiotic resistance

    • Metabolomic analysis to detect changes in cellular metabolism

    • Construction of catalytically inactive mutants as controls

  • Heterologous Expression Considerations:

    • Comparison of function in native vs. heterologous hosts

    • Assessment of proper membrane insertion and folding

    • Co-expression with partner proteins when required for function

Researchers should be particularly attentive to the potential for compensatory responses when manipulating ykkD expression, as observed in studies of other B. subtilis genes where knockout of multiple related genes did not necessarily produce additive effects due to complex regulatory interactions . Including appropriate time points for analysis is also critical, as some effects may be transient or develop only after extended growth periods.

What statistical approaches are most appropriate for analyzing ykkD-related resistance data?

  • MIC Data Analysis:

    • Implementation of at least 3-5 biological replicates for reliable MIC determination

    • Use of appropriate statistical tests for ordinal data (MICs typically follow 2-fold dilution series)

    • Application of non-parametric methods for comparing MIC distributions across strains

  • Growth Curve Analysis:

    • Fitting of parametric models (Gompertz, logistic, etc.) to extract biologically meaningful parameters

    • Mixed-effects modeling to account for plate-to-plate variation

    • Time-series analysis methods for detecting subtle growth differences

  • Transport Kinetics Data:

    • Non-linear regression for fitting enzyme kinetic models

    • Bootstrap methods for robust parameter estimation

    • Model selection approaches to identify the most appropriate kinetic model

  • High-dimensional Data Analysis:

    • Appropriate multiple testing correction for omics data

    • Dimension reduction techniques for visualizing complex datasets

    • Network analysis methods for identifying functional relationships

When analyzing data from chassis strain engineering experiments similar to those used for other B. subtilis modifications , researchers should implement statistical methods that can account for the hierarchical nature of the data (multiple measurements per strain, multiple strains per construct) and potential batch effects from independent experiments.

How can contradictory results in ykkD research be reconciled?

Reconciling contradictory results in ykkD research requires systematic investigation of potential sources of variation:

  • Strain Background Effects:

    • Direct comparison of experiments in identical genetic backgrounds

    • Systematic introduction of ykkD modifications into multiple strain backgrounds

    • Investigation of potential epistatic interactions with strain-specific genetic elements

  • Methodological Differences:

    • Detailed comparison of experimental protocols

    • Replication of key experiments using standardized methods

    • Collaborative studies between laboratories with contradictory results

  • Environmental Variables:

    • Systematic variation of growth conditions (media, temperature, pH)

    • Standardization of antibiotic preparation and storage

    • Control for batch-to-batch variation in reagents

  • Analytical Framework:

    • Development of mathematical models to explain apparently contradictory results

    • Meta-analysis of published data to identify patterns

    • Design of critical experiments specifically addressing contradictions

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.